Neonc Technologies (NTHI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
NTHI jumps 3.4% to $2.75. Closed at $2.75, +3.38% vs the prior close of $2.66. Day range $2.66–$2.80, opened at $2.66.
NTHI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NTHI jumps 3.4% to $2.75
- Closed at $2.75, +3.38% vs the prior close of $2.66. Day range $2.66–$2.80, opened at $2.66.
- Volume was 107.00K shares, 0.5x its 50-day average of 236.20K — lighter than usual.
- Price is -26.4% vs its 50-day average ($3.73) and -52.7% vs its 200-day average ($5.81).
- 52-week range $2.50–$12.00; today's close sits at 3% of that range, 77.1% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — NTHI rises 2.5% to $2.66
- Closed at $2.66, +2.50% vs the prior close of $2.60. Day range $2.55–$2.79, opened at $2.62.
- Volume was 133.20K shares, 0.6x its 50-day average of 234.69K — lighter than usual.
- Price is -29.1% vs its 50-day average ($3.75) and -54.4% vs its 200-day average ($5.84).
- 52-week range $2.50–$12.00; today's close sits at 2% of that range, 77.8% below the 52-week high.
Oct 13, 2026 — NTHI slides 4.9% to $2.60
- Closed at $2.60, -4.95% vs the prior close of $2.73. Day range $2.53–$2.87, opened at $2.71.
- Volume was 74.60K shares, 0.3x its 50-day average of 233.99K — lighter than usual.
- Price is -31.1% vs its 50-day average ($3.76) and -55.8% vs its 200-day average ($5.87).
- 52-week range $2.50–$12.09; today's close sits at 1% of that range, 78.5% below the 52-week high.
Oct 12, 2026 — NTHI dips 1.8% to $2.73
- Closed at $2.73, -1.80% vs the prior close of $2.78. Day range $2.57–$2.80, opened at $2.77.
- Volume was 98.00K shares, 0.4x its 50-day average of 233.30K — lighter than usual.
- Price is -27.8% vs its 50-day average ($3.78) and -53.7% vs its 200-day average ($5.90).
- 52-week range $2.50–$12.09; today's close sits at 2% of that range, 77.4% below the 52-week high.
Oct 9, 2026 — NTHI jumps 9.9% to $2.78
- Closed at $2.78, +9.88% vs the prior close of $2.53. Day range $2.50–$2.83, opened at $2.54.
- Volume was 165.90K shares, 0.7x its 50-day average of 230.57K.
- Price is -26.8% vs its 50-day average ($3.80) and -53.1% vs its 200-day average ($5.93).
- 52-week range $2.50–$12.10; today's close sits at 3% of that range, 77.0% below the 52-week high.
Oct 8, 2026 — NTHI slides 6.6% to $2.53, a 52-week low
- Closed at $2.53, -6.64% vs the prior close of $2.71. Day range $2.52–$2.75, opened at $2.72.
- Volume was 255.50K shares, 1.1x its 50-day average of 225.88K.
- Price is -33.6% vs its 50-day average ($3.81) and -57.5% vs its 200-day average ($5.95).
- 52-week range $2.52–$12.99; today's close sits at 0% of that range, 80.5% below the 52-week high.
Oct 7, 2026 — NTHI slides 9.4% to $2.71, a 52-week low
- Closed at $2.71, -9.36% vs the prior close of $2.99. Day range $2.65–$2.98, opened at $2.98.
- Volume was 228.70K shares, 1.0x its 50-day average of 222.36K.
- Price is -29.3% vs its 50-day average ($3.83) and -54.6% vs its 200-day average ($5.97).
- 52-week range $2.65–$12.99; today's close sits at 1% of that range, 79.1% below the 52-week high.
Oct 6, 2026 — NTHI rises 2.4% to $2.99
- Closed at $2.99, +2.40% vs the prior close of $2.92. Day range $2.92–$3.07, opened at $2.95.
- Volume was 173.70K shares, 0.8x its 50-day average of 219.27K.
- Price is -22.3% vs its 50-day average ($3.85) and -50.1% vs its 200-day average ($5.99).
- 52-week range $2.88–$12.99; today's close sits at 1% of that range, 77.0% below the 52-week high.
Oct 5, 2026 — NTHI dips 2.3% to $2.92, a 52-week low, 3 down days in a row
- Closed at $2.92, -2.34% vs the prior close of $2.99. Day range $2.88–$3.13, opened at $3.00.
- Volume was 197.20K shares, 0.9x its 50-day average of 216.45K.
- Price is -24.3% vs its 50-day average ($3.86) and -51.5% vs its 200-day average ($6.02).
- 52-week range $2.88–$12.99; today's close sits at 0% of that range, 77.5% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — NTHI dips 2.3% to $2.99
- Closed at $2.99, -2.29% vs the prior close of $3.06. Day range $2.95–$3.18, opened at $3.06.
- Volume was 234.70K shares, 1.1x its 50-day average of 212.23K.
- Price is -22.7% vs its 50-day average ($3.87) and -50.6% vs its 200-day average ($6.05).
- 52-week range $2.95–$12.99; today's close sits at 0% of that range, 77.0% below the 52-week high.
NTHI latest news & SEC filings
Every SEC filing by or about NTHI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Garnett Keithly sold 5,000 shares at $3.36 (≈$16.81K) on Sep 15, 2026; now holds 237,357
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Heshmatpour Amir F bought 35,000 shares at $3.30 (≈$115.50K) on Sep 15, 2026
- Heshmatpour Amir F bought 15,000 shares at $3.96 (≈$59.40K) on Sep 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chen Thomas C bought 5,242 shares at $3.82 (≈$20.02K) on Sep 14, 2026
- Chen Thomas C bought 5,556 shares at $3.60 (≈$20.00K) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Garnett Keithly bought 257 shares at $3.89 (≈$1,000) on Sep 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 10, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 21, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade NTHI
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 18, 2026, Apr 3, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.37% (largest 10.1%). That is a volatile stock.
- Liquidity: about 169.28K shares (≈$465.51K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.75 vs a range of $2.50–$12.00 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 24 open-market buys, 1 sales; latest: Keithly Garnett sold 5,000 shares on Sep 15, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Sep 28, 2026; 8-K Sep 21, 2026.
- Share count: 25.94M shares outstanding (Aug 10, 2026), +35.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
NTHI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 2.66 | 2.80 | 2.66 | 2.75 | 107.00K |
| Oct 14, 2026 | 2.62 | 2.79 | 2.55 | 2.66 | 133.20K |
| Oct 13, 2026 | 2.71 | 2.87 | 2.53 | 2.60 | 74.60K |
| Oct 12, 2026 | 2.77 | 2.80 | 2.57 | 2.73 | 98.00K |
| Oct 9, 2026 | 2.54 | 2.83 | 2.50 | 2.78 | 165.90K |
| Oct 8, 2026 | 2.72 | 2.75 | 2.52 | 2.53 | 255.50K |
| Oct 7, 2026 | 2.98 | 2.98 | 2.65 | 2.71 | 228.70K |
| Oct 6, 2026 | 2.95 | 3.07 | 2.92 | 2.99 | 173.70K |
| Oct 5, 2026 | 3.00 | 3.13 | 2.88 | 2.92 | 197.20K |
| Oct 2, 2026 | 3.06 | 3.18 | 2.95 | 2.99 | 234.70K |
| Oct 1, 2026 | 3.37 | 3.38 | 3.05 | 3.06 | 161.00K |
| Sep 30, 2026 | 3.28 | 3.47 | 3.19 | 3.40 | 131.30K |
| Sep 29, 2026 | 3.35 | 3.50 | 3.12 | 3.30 | 180.90K |
| Sep 28, 2026 | 3.24 | 3.43 | 3.16 | 3.16 | 108.70K |
| Sep 25, 2026 | 3.36 | 3.52 | 3.25 | 3.31 | 135.20K |
| Sep 24, 2026 | 3.39 | 3.60 | 3.23 | 3.30 | 202.90K |
| Sep 23, 2026 | 3.44 | 3.52 | 3.12 | 3.22 | 96.00K |
| Sep 22, 2026 | 3.33 | 3.49 | 3.31 | 3.45 | 146.40K |
| Sep 21, 2026 | 3.30 | 3.48 | 3.28 | 3.33 | 135.40K |
| Sep 18, 2026 | 3.63 | 3.68 | 3.19 | 3.26 | 419.20K |
About Neonc Technologies
Neonc Technologies (NTHI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CALABASAS, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1979414.
NTHI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Thomas C Chen | CEO | Sep 15, 2026 |
| Ming-Fu (Alan) Chiang | Director | Nov 24, 2025 |
| Amir F Heshmatpour | CEO, President | Sep 15, 2026 |
| Nasim Shomali | Director | Jul 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Thomas C Chen | CEO | Sep 15, 2026 |
| Keithly Garnett | CFO | Sep 18, 2026 |
| Amir F Heshmatpour | CEO, President | Sep 15, 2026 |
| Yousha Neman-Ebrahim | Chief Clinical Officer | Apr 24, 2026 |
| David Jr. Suh, | Chief Accounting Officer | Apr 13, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Keithly Garnett | Sale | 5,000 | $3.36 |
| Sep 15, 2026 | Amir F Heshmatpour | Buy | 35,000 | $3.30 |
| Sep 14, 2026 | Keithly Garnett | Buy | 257 | $3.89 |
| Sep 14, 2026 | Thomas C Chen | Buy | 5,242 | $3.82 |
| Sep 14, 2026 | Amir F Heshmatpour | Buy | 15,000 | $3.96 |
| Sep 11, 2026 | Thomas C Chen | Buy | 5,556 | $3.60 |
| Sep 11, 2026 | Amir F Heshmatpour | Buy | 37,000 | $3.67 |
| Aug 18, 2026 | Thomas C Chen | Buy | 12,757 | $5.49 |
| Aug 18, 2026 | Amir F Heshmatpour | Buy | 9,000 | $5.54 |
| Aug 17, 2026 | Thomas C Chen | Buy | 2,472 | $4.04 |
| Aug 17, 2026 | Thomas C Chen | Buy | 2,472 | $4.04 |
| Aug 17, 2026 | Amir F Heshmatpour | Buy | 3,000 | $4.37 |
| Aug 14, 2026 | Thomas C Chen | Buy | 33,787 | $3.85 |
| Aug 14, 2026 | Thomas C Chen | Buy | 33,787 | $3.85 |
| Aug 14, 2026 | Amir F Heshmatpour | Buy | 12,000 | $3.79 |
NTHI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $39.99K | $-62.15M | -3.20 | $-20.36M |
| Dec 31, 2024 | $83.00K | $-11.90M | -0.69 | $-4.21M |
Latest balance sheet: total assets $5.23M, total liabilities $23.76M, cash $1.97M (as of Jun 30, 2026).
NTHI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $3.50 |
| May 18, 2026 | 8-K Item 2.02 (results) | $5.34 |
| Apr 3, 2026 | 8-K Item 2.02 (results) | $5.74 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $9.08 |
| Aug 22, 2025 | 8-K Item 2.02 (results) | $5.82 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)AMD (AMD)Apple (AAPL)Tesla (TSLA)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NTHI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.